Inhibitors of phosphopantetheine adenylyltransferase.

Eur J Med Chem

Department of Chemistry, PanTherix Ltd, West of Scotland Science Park, Todd Campus, G20 0XA, Glasgow, UK.

Published: April 2003

Phosphopantetheine adenylyltransferase (PPAT) is an essential enzyme in Coenzyme A biosynthesis. Because bacterial PPAT and mammalian PPAT are dissimilar, this enzyme is an attractive antibacterial target. Based on the structure of the substrate, 4-phosphopantetheine, a dipeptide library was designed, synthesised and tested against Escherichia coli PPAT. The most potent inhibitor PTX040334 was co-crystallised with E. coli PPAT. With this structural information, a rational iterative medicinal chemistry program was initiated, aimed at increasing the number of inhibitor-enzyme interactions. A very potent and specific inhibitor, PTX042695, with an IC(50) of 6 nM against E.coli PPAT, but with no activity against porcine PPAT, was obtained.

Download full-text PDF

Source
http://dx.doi.org/10.1016/s0223-5234(03)00047-3DOI Listing

Publication Analysis

Top Keywords

phosphopantetheine adenylyltransferase
8
coli ppat
8
ppat
7
inhibitors phosphopantetheine
4
adenylyltransferase phosphopantetheine
4
adenylyltransferase ppat
4
ppat essential
4
essential enzyme
4
enzyme coenzyme
4
coenzyme biosynthesis
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!